BioScrip Inc Stock Nasdaq
Equities
US09069N1081
Healthcare Facilities & Services
Sales 2024 * | 4.75B 6.5B | Sales 2025 * | 5.18B 7.08B | Capitalization | 4.81B 6.58B |
---|---|---|---|---|---|
Net income 2024 * | 203M 278M | Net income 2025 * | 234M 320M | EV / Sales 2024 * | 1.14 x |
Net Debt 2024 * | 598M 817M | Net Debt 2025 * | 400M 547M | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
23.8
x | P/E ratio 2025 * |
20.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.86% |
Latest transcript on BioScrip Inc
Managers | Title | Age | Since |
---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 57 | 19-08-05 |
Michael Shapiro
DFI | Director of Finance/CFO | 53 | 14-12-31 |
Caroline Budde
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Kraemer
CHM | Chairman | 69 | 19-08-06 |
David Golding
BRD | Director/Board Member | 62 | 15-04-30 |
John Arlotta
BRD | Director/Board Member | 74 | 19-08-06 |
1st Jan change | Capi. | |
---|---|---|
+18.69% | 84.15B | |
-25.20% | 74.14B | |
+1.06% | 26.92B | |
-10.46% | 17.15B | |
-0.68% | 16.83B | |
-0.73% | 15.21B | |
+72.88% | 13.3B | |
+76.04% | 12.99B | |
-25.79% | 12.79B |